Role of circadian clock in oral squamous cell carcinoma pathogenesis and treatment

Mingyuan Liu1, Kai Yang1

  • 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1, Youyi Road, Yuzhong District, Chongqing, 400016, China.

Insights

Circadian clock disruption is linked to oral squamous cell carcinoma (OSCC) development. This review explores chronotherapy and gene-targeting strategies for OSCC prevention and treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Chronobiology

Background:

  • The circadian clock, a molecular timing system, regulates cellular functions via clock genes.
  • Disruption of the circadian clock is implicated in various cancers, affecting homeostasis.
  • Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with unclear onset mechanisms.

Purpose of the Study:

  • To review the role and mechanisms of circadian clock disruption in OSCC development and progression.
  • To summarize advances in chronotherapy and therapeutic strategies targeting circadian clock genes for OSCC.

Main Methods:

  • Literature review focusing on circadian clock genes, OSCC, and chronotherapy.
  • Analysis of molecular pathways linking circadian disruption to cancer.
  • Synthesis of current therapeutic strategies and future directions.

Main Results:

  • Circadian clock disruption contributes to OSCC initiation and advancement.
  • Chronotherapy and targeted gene therapies show promise for OSCC treatment.
  • Understanding these mechanisms offers new avenues for OSCC prevention.

Conclusions:

  • Circadian clock disruption is a significant factor in OSCC.
  • Targeting the circadian clock presents novel therapeutic opportunities for OSCC.
  • Further research is crucial for developing effective chronotherapies for OSCC.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...